A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat Tuberculosis

Affiliations

Editorial

Sofia Zavala et al. Am J Respir Crit Care Med. 2024.

. 2024 Dec 1;210(11):1295-1296.

doi: 10.1164/rccm.202406-1262ED.

¹ Department of Medicine Duke University School of Medicine Durham, North Carolina.

No abstract available

Comment on

Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.
Xu AY, Velásquez GE, Zhang N, Chang VK, Phillips PPJ, Nahid P, Dorman SE, Kurbatova EV, Whitworth WC, Sizemore E, Bryant K, Carr W, Brown NE, Engle ML, Nhung NV, Nsubuga P, Diacon A, Dooley KE, Chaisson RE, Swindells S, Savic RM. Xu AY, et al. Am J Respir Crit Care Med. 2024 Dec 1;210(11):1358-1369. doi: 10.1164/rccm.202401-0165OC. Am J Respir Crit Care Med. 2024. PMID: 39012226 Free PMC article. Clinical Trial.

1. Combs DL, O’Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med . 1990;112:397–406. - PubMed
1. Chirehwa MT, McIlleron H, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, et al. Pharmacokinetics of pyrazinamide and optimal dosing regimens for drug-sensitive and -resistant tuberculosis. Antimicrob Agents Chemother . 2017;61:e00490–17. - PMC - PubMed
1. Sahota T, Della Pasqua O. Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosis. Antimicrob Agents Chemother . 2012;56:5442–5449. - PMC - PubMed
1. Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, Wells CD, et al. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis . 2009;48:1685–1694. - PMC - PubMed
1. Zhang N, Savic RM, Boeree MJ, Peloquin CA, Weiner M, Heinrich N, et al. Tuberculosis Trials Consortium (TBTC) and Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) Networks Optimising pyrazinamide for the treatment of tuberculosis. Eur Respir J . 2021;58:2002013. - PMC - PubMed